State of Health Episode 21: Antibiotic Resistance: How CARB-X Helps New Companies Get a Running Start

Kevin Outterson, the Executive Director of Boston-based CARB-X, a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria, joins the podcast to talk with Gunnar about the early-stage landscape for biotechnology companies developing novel antibiotics. Unlike the AMR ActionFund, CARB-X doesn’t take equity positions in new companies,...
Continue reading...

State of Health Episode 19: Antibiotic Resistance: PASTEUR Act with Senator Michael Bennet

Senator Michael Bennet, a co-sponsor of the bipartisan PASTEUR Act, joins Gunnar on the State of Health to talk about his proposed legislation to correct the dysfunctional antibiotic market. Senator Bennet makes his pitch for why he believes people should care about antibiotic resistance, talks about how the PASTEUR Act can become law, and shares...
Continue reading...

State of Health Episode 18: Antibiotic Resistance: Investing in the Next Generation of Antibiotics

The State of Health continues the Antibiotic Resistance series with an episode featuring Henry Skinner, the CEO of the AMR Action Fund, a novel kind of investment fund that aims to catalyze the innovation ecosystem for novel antibiotics. Gunnar and Henry talk about the challenges of bringing new antibiotics to market, the difference between the...
Continue reading...

State of Health Episode 15: Immunocompromised Transplant Patients Return to Vaccine Clinics for Booster Shots

Katy Monte, an immunocompromised woman who has received three transplants as a result of her end-stage cystic fibrosis, talks to Gunnar about getting a third COVID-19 vaccine after the FDA recommended booster shots for people who may not have developed antibodies after the initial doses. She explains the conversations she had with her care teams,...
Continue reading...